Branning Todd P. 4
4 · Amneal Pharmaceuticals, Inc. · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Branning Todd P.
SVP, Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option
2019-11-13−163,666→ 0 totalExercise: $12.44Exp: 2029-01-22→ Class A Common Stock (163,666 underlying) - Award
Stock Option
2019-11-13+163,666→ 163,666 totalExercise: $2.75Exp: 2029-01-22→ Class A Common Stock (163,666 underlying)
Footnotes (1)
- [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.